Search by Drug Name or NDC

NDC 68462-0221-11 Lithium Carbonate 300 mg/1 Details

Lithium Carbonate 300 mg/1

Lithium Carbonate is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Glenmark Pharmaceuticals Inc., USA. The primary component is LITHIUM CARBONATE.

MedlinePlus Drug Summary

Lithium is used to treat and prevent episodes of mania (frenzied, abnormally excited mood) in people with bipolar disorder (manic-depressive disorder; a disease that causes episodes of depression, episodes of mania, and other abnormal moods). Lithium is in a class of medications called antimanic agents. It works by decreasing abnormal activity in the brain.

Related Packages: 68462-0221-11
Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Lithium

Product Information

NDC	68462-0221
Product ID	68462-221_cdd20960-5c1d-40fc-8f45-572d5bd58fe1
Associated GPIs	59500010100105
GCN Sequence Number	004001
GCN Sequence Number Description	lithium carbonate CAPSULE 300 MG ORAL
HIC3	H2M
HIC3 Description	BIPOLAR DISORDER DRUGS
GCN	15710
HICL Sequence Number	001669
HICL Sequence Number Description	LITHIUM CARBONATE
Brand/Generic	Generic
Proprietary Name	Lithium Carbonate
Proprietary Name Suffix	n/a
Non-Proprietary Name	Lithium Carbonate
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	CAPSULE
Route	ORAL
Active Ingredient Strength	300
Active Ingredient Units	mg/1
Substance Name	LITHIUM CARBONATE
Labeler Name	Glenmark Pharmaceuticals Inc., USA
Pharmaceutical Class	Mood Stabilizer [EPC]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA079139
Listing Certified Through	2024-12-31

Package

NDC 68462-0221-11 (68462022111)

Pricing Information	N/A
NDC Package Code	68462-221-11
Billing NDC	68462022111
Package	10 BLISTER PACK in 1 CARTON (68462-221-11) / 10 CAPSULE in 1 BLISTER PACK
Marketing Start Date	2009-02-03
NDC Exclude Flag	N